Lytus Technologies Holdings Private Limited ( (LYT) ) just unveiled an update.
Lytus Technologies Holdings received a Nasdaq determination letter on February 11, 2025, indicating non-compliance with the minimum bid price requirement, risking delisting. The company has requested a hearing to appeal the decision, with its shares continuing to trade pending the outcome. Simultaneously, Lytus is strengthening its HealthTech position with its subsidiary, Lytus Healthcare, aiming to enhance patient care in India. The company has reported a 26% revenue growth for the first half of FY2025 and secured strategic financing to support its expansion initiatives, including a $100 million Standby Equity Purchase Agreement.
More about Lytus Technologies Holdings Private Limited
Lytus Technologies is a NASDAQ-listed company focusing on platform services and next-generation technology solutions. It operates in digital streaming, HealthTech, fintech, AI, and cybersecurity sectors across India and international markets, serving a base of 4 million active customers.
YTD Price Performance: -70.35%
Average Trading Volume: 1,889,609
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.82M
For detailed information about LYT stock, go to TipRanks’ Stock Analysis page.